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Summary
Although there is widespread acceptance that total cholesterol
(TC) value reference ranges should be based on epidemio-
logical rather than statistical considerations, the epidemio-
logical action limits for Iow-density lipoprotein cholesterol
(LDL-C) are still incomplete and only statistical reference
ranges for apolipoprotein B (Apo-B) levels are available. The
combined use of epidemiological reference ranges for TC
and incomplete or statistical reference ranges for LDL-C and
Apo-B is illogical, since these parameters may fall into dis-
cordant risk categories that will hamper and complicate the
management of hypercholesterolaemia.
Based on a study of Iipograms obtained from ± 3 000
inhabitants of two industrialised Transvaal towns, the age-
related epidemiological reference ranges for LDL-C and Apo-
B were established. A comparison with published observa-
tional studies of other populations, in which comparable lipid,
lipoprotein and apolipoprotein methodologies were used,
reflected the severity of these lipid-related abnormalities in
white South Africans, especially after the age of 30 years. In
addition, the serum TC values found in this survey were not
significantly different from those obtained 10 years ago.
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Atherosclerosis, the leading cause of death in the Western
world, begins early in life .and progresses silently for decades.
By the time most individuals develop clinical manifestations of
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ischaemic heart disease (IHD), the atherogenic process is far
advanced. Sudden death can be the first manifestation of
atherosclerosis and even in non-fatal cases coronary bypass
surgery may not prolong survival in patients with advanced
disease. 1 The early identification and modification of risk
factors are therefore essential. The use ora statistically derived
reference range (population average ± 2 SD) to identify
hypercholesterolaemia as one of the major modifiable risk
factors, was based on the mistaken view that what is common
is also good and therefore normal. Authoritative epidemiological
surveys2-4 have, in fact, shown that the relationship between
cholesterol and IHD is continuous and curvilinear. This means
. that there is an increased risk of fatal IHD associated with
serum total cholesterol (TC) levels throughout much of the
range of values previously thought to be 'safe'. Consequently,
the assessment of an individual patient's lipid proflle should
not be based on conventionally (statistically) determined
reference intervals, a mistake responsible for inconsistent con-
clusions in early attempts to correlate serum lipid concentra-
tions and atherogenesis. The curvilinear relationship between
the incidence of IHD and TC levels suggests that cholesterol
levels can be divided into three categories: desirable, moderate
and high, depending on the relative risk of developing IHD. A
comparison of the epidemiological data obtained from a local
coronary risk factor study (CORIS)5 in a white rural population
and the Multiple Risk Factor Intervention Trial (MRFIT),3
suggests that the 20th and 80th percentiles of TC distribution
in the CORIS population should be used to distinguish between
these three categories. These percentiles were recently put
forward as the new cholesterol guidelines for South Africa,6
based on the assumption that these age-related cut-off points
would also apply to free-living communities with a Western
lifestyle elsewhere in this country.
In most circumstances non-fasting serum TC estimations
are adequate for screening and monitoring purposes. However,
a lipogram consisting of low-density lipoprotein cholesterol
(LDL-C) and high-density lipoprotein cholesterol (HDL-C) is
recommended for subjects with TC values falling into -the
high-risk category or subjects in the moderate-risk category
who have additional risk factors. 6 A refmement of lipid risk
factor analyses (LDL-C and HDL-C) has been shown to
improve the prediction of the development of IHD.7 Another
reason for a more detailed lipid analysis is to exclude the
occasionally elevated TC level caused by high HDL-C values
but with normal LDL-C concentrations. Such subjects are not
at an increased risk of IHD and therefore require no further
intervention. Age-related epidemiological reference ranges are
also required for LDL-C if the additional information provided
by a lipogram is to be effectively utilised. A complete set of
such LDL-C action limits for a South African population have
not yet been determined. In many laboratories in this country,
lipograms have also recently been extended to include the
major apolipoproteins of LDL (Apo-B) and HDL (Apo-Al).
Epidemiological surveysS-lO have shown that these parameters
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could provide an even better indicator of risk than the currently
used lipid (TC, LDL-C and HDL-C) analyses. The currently
published cut-off points for Apo-B are all based on statistically
determined reference ranges. However, the use of a continuum
of age-related, epidemiological reference ranges in conjunction
with statistically determined reference ranges may lead to
situations where TC, LDL-C andlor Apo-B may fall into
different risk categories. This may create practical, interpre-
tative and management problems. The fIrst aim of this study
was therefore to test the assumption that the CORIS popu-
lation, which formed the basis of South African TC epidemio-
logical reference ranges, is representative of other free-living
communities with a Western lifestyle. The second object was'
to provide a complete set of epidemiological action limits for
LDL-C and Apo-B to facilitate interpretations of lipograms,
which may lead to important decisions regarding the manage-
ment of patients.
Subjects and methods
apolipoproteinsp were used in conjunction with commercial
QC sera obtained from Behringwerke. An external QC pro-
gramme for apolipoproteins verifIed that the analytical perfor-
mance had been within 2SD of the mean that was obtained by
other laboratories using comparable methods.
Data were compiled and analysed by Central Statistical
Services and the Institute for Biostatistics of the South African
Medical Research Council. The survey was approved by the
ethical committee of the Department of Health Services and
Welfare.
Results and discussion
The similarity between the actual ('unsmoothed') values of the
20th and 80th percentiles of the industrialised Transvaal P9pu-
lation and the corresponding percentiles obtained from a
smoothed graph of TC percentiles6 from the rural western
Cape population is obvious (Table I). It was also statistically
TABLE 11. CUT-OFF POINTS FOR LDL-C TO DISTINGUISH
BETWEEN MODERATE-RISK AND HIGH-RISK CATEGORIES
TABLE I. A COMPARISON OF THE 20TH AND 80TH
PERCENTILES OF TC (mmol/l) DISTRIBUTION IN A RURAL
WHITE POPULATION (CORIS) AND IN AN INDUSTRIALISED
POPULATION ACCORDING TO DIFFERENT AGE CATEGORIES
IN BOTH SEXES
confIrmed with correlation coefficients of 0,92 and 0,98 for the
20tl1 and 80th percentiles, respectively. This is the fIrst age-
related comparison with the CORIS data, which repres~nt the
largest and best-documented regional population survey in
South Africa. The aforementioned two percentiles, which




































































































During 1988 a survey of the white population of two industrial
towns (Vanderbijlpark and Witbank) in the Transvaal was
undertaken as part of the VIGHOR study [Vanderbijlpark
Information project re: GesondheidlHealth Obesity Risk
factors]. A stratifIed random sample of 1500 persons between
the ages of 16 years and 64 years was drawn from each of the .
communities. The 1985 population census was used as a basis
for the calculations and the Telephone Directory was the
source from which individual households were drawn. A pro-
portional number of households from each letter of the alphabet
was called and 1 individual was randomly selected to participate
in the survey. The survey fmally included 1407 individuals
from Vanderbijlpark and 1360 from Witbank. Blood samples
were taken without prolonged venous occlusion after patients
had been sitting for 5 minutes.
Laboratory analyses consisted of TC, HDL-C, LDL-C,
Apo-B and Apo-AI determinations. TC levels were measured
by automated enzymatic procedures on a Technicon SMAC
system. ll To determine HDL-C, LDL and VLDL were pre-
cipitated from serum using heparin and Mg++ (Merck reagent
kit 15007); the supernatant was used to determine HDL-C by
means of the CHOD-Iodide method (Merck kit 14350). For
the determination of LDL-C, LDL was precipitated from
serum by heparin at its iso-eleetric point (Merck reagent kit
14992). After centrifugation, the cholesterol content of the
supernatant was determined and this equalled the sum of
HDL-C and VLDL-C. LDL-C was then calculated by:
LDL-C = TC - (HDL-C + VLDL-C). Results obtained
with this differential precipitation method for LDL-C in non-
fasting subjects did not differ statistically signillcantly (P >
0,05; Student's I-test) from the calculated LDL-C in the
same, but fasting, subjects using the Friedewald equation
[LDL-C = TC - (HDL-C + Tgs/2,18)].
Commercial quality control (QC) sera were included in each
batch and the results of the unknown samples were accepted
only if the QC values had fallen within two standard deviations
(SD) of the mean provided by the manufacturer. The coeffi-
cient of variation for TC, determined on the QC material,
during the smdy period was 2,0%. Results from an external
QC programme confIrmed that there had been no biases in
TC determinations and that the analytical process had been
properly controlled. Apo-Al and Apo-B were determined by
immunonephelometric assays (INA) using the Behring Laser
Nephelometer and methods (Behring reagent kits OSAN 14115
and OUED for Apo-B and Apo-Al respectively). Apolipo-
protein standards, which were calibrated against the proposed
International Union of Immunological Societies and the
Centers for Disease Control (IUIS-CDC) reference pool for
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respond with the 40th and 85th percentiles of TC distribution
in the MRFIT srody,5,6 respectively. This illustrates the severity
and increased relative risk in white South Africans of develop- It> It>
ing IHD. It is therefore not surprising that it has been It> M N ~'":=- It> .... It> CD'"
suggested that the incidence of IHD in white South Africans ....
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an increased demand for lipograms may be experienced. Such
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"Prevalence Srody2 should be used for LDL-C cut-Off points. z
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the assessment of premature atherosclerotic disease. «
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TABLE Ill. CUT-OFF POINTS FOR APO-B (g/l) TO en >- CDOMU'JCO
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Since apolipoprotein proflling has also become common
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practice in many private laboratories, guidelines about such
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and Apo-B discriminate better between individuals with angio- «
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graphically documented IHD and normal· subjects than does '-?--'
the cholesterol level of the corresponding lipoprotein.8,9 There 0--'




'"now well recognised that the content of cholesterol ester '" '" '" '" u2:: N M .... It> 0 ....
within the core of LDL may increase, producing a more 4> '"
,.,
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buoyant 'light' LDL particle, or decrease, yielding a denser « N
M .... It> + 0
'heavy' LDL particle. The light or heavy particles each contains
only 1 molecule of Apo-B and the measurement of LDL Apo-
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TABLE V. PERCENTAGES OF VARIOUS POPULATIONS IN SA RISK CATEGORIES
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B can thus provide a more accurate assessment of the number
ofLDL particles than measurement ofLDL-C alone. Sniderman
et a/. ls found that the majority of the patients they studied
with angiographically documented IHD had elevated levels of
Apo-B and normal levels of LDL-C. They introduced the'
term 'hyperapobeta-lipoproteinaemia' or 'hyperapo B' to dis-
tinguish this condition from hyperbeta-lipoproteinaemia (type
11 hypercholesterolaemia), in which both LDL-C and Apo-B
are elevated. Since the LDL particle is depleted in cholesterol
esters, the patient is usually 'normocholesterolaemic' or has
only a borderline high cholesterol level. Because of the altered
composition of LDL, the elevated LDL levels in hyperapo-B
can be detected more accurately by measuring Apo-B than by
measuring LDL-C. It has been shown that heavy (dense)
LDL particles were removed at a slower rate than the light
LDL particles.J4 Thus, while there is no apparent defect in the
LDL receptor in hyperapo-B, the shift to the denser LDL
particles is not advantageous, because dense LDLs have a
longer residence time in plasma than light LDL. This obser-
vation suggests that dense LDL might bind less well to LDL
receptors than light LDL. For this reason, it is perhaps not
surprising that Apo-B is a better risk predictor than LDL-C;
the latter does not accurately reflect the increased LDL particles
in hyperapo-B patients.
Based on the new epidemiological defInition of 'normal
cholesterol value', it is reasonable to expect that optimum!
desirable ranges should be similarly set for apolipoproteins.
Regression analysis. on approximately 3000 individuals in this
study has given a correlation coeffIcient of r =0,82; P < 0,001
between Apo-B and LDL-C values. Since the 20th and 80th
percentiles of TC and LDL-C in the South African adult
population seem to correlate well with suggested action limits
derived from large epidemiological studies abroad,2 and because
ofthe good correlation between Apo-B and LDL-C, it can be
argued that the same percentiles may serve as appropriate
epidemiological guidelines for Apo-B action limits (Table Ill).
Until now, however, most published reports on Apo-AI and
Apo-B levels have provided only statistical reference ranges of
the populations investigated. ID In order for cut-<lff points to be
used on a national basis, evaluation and specillcations of the
methods involved are essential. Various immunochemical
methods which differ in principle and sensitivity have been
used in these studies. At present, efforts are underway to
develop reference material and standardisation programmes
for apolipoproteins. 12 The two methods most commonly used
by pathology laboratories in this country, radio-immunoassay
(RIA) and immunonephelometric assay (INA), show a good
correlation (under optimal conditions) over a broad range of
Apo-AI and Apo-B values with the specially prepared reference
materials of the Standardisation Committee of the IUIS-
CDC. 16 It is only to be expected that inter-laboratory metho-
dological differences in routine laboratories may be larger than
those reported,16 since these assays are not-usually as rigorously
standardised as in a research setting. Despite these" reservations,
a recent authoritative comparisonl7 has shown an excellent
agreement between the Behring nephelometrically determined
Apo-B and a highly standardised RIA Apo-B method (r =
0,91, standard error of the estimate 0,012 g/l, slope 1,03 and
the intercept 3,3). However, using another commercial
nephelometer and method, a bias of approximately -30% for
Apo-B was demonstrated.
A comparison ofTC, LDL-C and Apo-B of South Africans
with that of a low-risk group, such as the Italians,18 and a
recently surveyed high-risk group, such as the British,19 corro-
borates the suggestionl3 that white South Mricans may have a
particularly severe lipid problem (Table IV). The comparative
increase in Apo-B over the same age interval for the Mediter-
ranean population was approximately 0,2 g/l and for the
South Africans 0,4 g/l. This difference in Apo-B concentration
corresponds with the magnitude of change in the lipid concen-
trations. This unfavourable disposition towards lipid-related
risk factors may, in addition, be aggravated by the smaller/
denser LDL particles (lower LDL-C/Apo-B ratio) in South
Mricans, which remained remarkably constant throughout the
different age categories. The South African LDL-C/Apo-B
ratio was approximately 3,0 v. 3,5 for Italians. 18 However,
these apparent differences in the LDL particle size should be
further investigated before the impression that this may also
be a population characteristic, predisposing to IHD, can be
confIrmed. The age-related deterioration of South African
lipid risk factors is also borne out when the lipid (TC and
LDL-C) levels are compared with UK communities known to
have an unacceptably high IHD risk (Table IV). When the
South Arican epidemiological limits for TC are used to desig-
nate the British and Italian populations to one of the three risk
categories (Table V), it is evident that a smaller percentage of
British and a very small percentage of Italians « 1%) would
fall into the high-risk category for South Mricans (calculations
by P.J.B.). This comparison further suggests that the action
limits for South Mricans previously determined6 are" not
unrealistic and, indeed, attainable in that < I% of an age-
matched Italian population would fall into the high-risk
category of South Africans (Table V). Drug treatment" is
usually reserved for non-responders in this category.
In their recent report on aprospective study in the UK,
Pocock et al.2D have once again shown that the increases in risk
associated with elevated TC and depressed HOL-C levels
seemed to operate independently of one anotlier. The pro-
posed6 HDL-C action limit for South Africa is 1,0 mmol/l,
below which risk increases. In this study the mean Apo-AI
concentration, which corresponds with a HDL-C value of 1,0
mm01l1 for the population as a whole, is 1,31 g/l. In contrast
with the good agreement between RIA and INA-determined
Apo-B levels, there is a divergence between these two methods
with respect to Apo-AIY
In conclusion, a comparison of the present epidemiological
survey with the CORIS study shows that the TC levels in the
different age categories are very similar which implies: (t) that
the epidemiological action limits based on the CORIS data"are
also applicable to other communities with a similar lifestyle in
South Mrica; and (il) that the TC levels in South Africa have
probably not decreased despite various campaigns to increase
public awareness about the risk associated with high cholesterol
levels. Previous comparisons6 with other high-risk populations,
e.g. the MRFIT study,3 showed that TC distributions in
South Mricans were upwardly displaced. A comparison of the
refmement of lipid risk factors (LDL-C and Apo-B) with
those obtained from UK and Italian populations confIrms this
upward displacement of lipid risk factors and emphasises the
need for strategies to reduce the extent of this major risk factor
in white, Asian and urban coloured South Mricans. Since a
large percentage of South Mricans with a First-World lifestyle
would be further investigated by means of LDL-C and even
Apo-B determinations, we believe that epidemiological age-
'related cut-off points for these two parameters are prerequisites,
since it has been adequately documented that statistically
'normal' values for TC, LDL-C and Apo-B are a contradiction
in terms.
This work was supponed in pan by research grants from the
Meat Board, Dairy Service Organisation and the South African
Medical Research Council.
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